ADC Therapeutics SA (ADCT) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Adc Therapeutics Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.398 Good morning, ladies and gentlemen, and welcome to ADC Therapeutics' first 00:00:05.398 -- 00:00:10.424 quarter 2025 earnings call. At this time, all lines are in 00:00:10.424 -- 00:00:15.631 a listen-only mode. Following the presentation, we will conduct a question 00:00:15.631 -- 00:00:20.998 and answer session. If anyone has any difficulties hearing the conference, 00:00:20.998 -- 00:00:25.083 please press star zero for operator assistance at any time. 00:00:25.083 -- 00:00:29.630 I would now like to turn the conference call over to Marcie Graham, investor relations 00:00:29.630 -- 00:00:34.053 and corporate affairs officer. Please go ahead. 00:00:35.458 -- 00:00:36.340 Thank you, operator. 00:00:36.340 -- 00:00:41.447 Today we issued a press release announcing our first quarter 2025 financial results 00:00:41.447 -- 00:00:45.613 and business update. This release and the slides we will use in today's presentation 00:00:45.613 -- 00:00:50.420 are available on the investor section of the ADC Therapeutics website. 00:00:50.420 -- 00:00:54.867 I'm joined on today's call by our chief executive officer, Amit Malik, who will discuss 00:00:54.867 -- 00:00:57.693 our operational performance and recent business highlights. 00:00:57.693 -- 00:01:01.740 our Chief Medical Officer, Mohammad Zaki, who will discuss our clinical programs and 00:01:01.740 -- 00:01:06.187 updates, followed by our Chief Financial Officer, Pepe Carmona, who will review our first 00:01:06.187 -- 00:01:11.396 quarter 2025 financial results. We will then open the call for questions. 00:01:11.396 -- 00:01:15.162 Before we begin, I would like to remind listeners that some of the statements made during 00:01:15.162 -- 00:01:18.969 this conference call will contain forward...